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ABSTRACT 
A set of growth regulating genes has been identified that decline in expression in organs 
with age. This downregulation is thought to coordinate organ growth cessation observed as 
humans and animals mature. The objective of this study was to observe the expression of 7 of 
these growth regulating genes (Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1) in male and 
female skeletal muscle, heart, and liver with age. It was hypothesized that the expression of these 
genes would differ not only between sexes, but also between tissues. Female and male C57BL/6J 
mice were sacrificed at 1, 7, 21, 35, and 49 days of age. Samples collected consisted of heart and 
liver from all mice, all muscles from both hind limbs of 1- and 7-day-old mice, and specific 
muscles (bicep femoris, gastrocnemius, tibialis anterior, and triceps brachii) from 21-, 35-, and 
49-day-old mice. Expression was determined by quantitative real-time PCR, normalized to 
Rn18s, standardized to a single 1-day-old male liver sample present on each plate, and compared 
to the average of 1-day-old male expression for each tissue. Data were analyzed using the Proc 
Mixed procedure in SAS as repeated measures with significant differences (P < 0.05) determined 
by a Bonferroni-adjusted pdiff. Orthogonal contrasts were used to differentiate between linear, 
quadratic, and cubic patterns of expression among tissues. In general, expression declined from 1 
or 7 days of age when compared to 49 days of age for all the genes in all the tissues except for 
expression of Ezh2 and Mycn, which was not altered by age in liver. Some differences in 
expression were observed between sexes with the majority of the differences occurring at 49 
days. Expression was usually increased in females compared with males at this time point. 
Occasionally, males had greater expression than females; this was observed in liver at 1 day of 
age for Gpc3, Mest, and Plagl1 and muscle at 35 days of age for Mest. There were some 
similarities in the patterns of gene expression between muscle and heart or liver, but, there was 
not a single gene that had the same pattern of expression in all 3 tissues. Overall, these data 
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suggest that the downregulation of these growth regulating genes with age might play a role in 
the coordinated cessation of muscle growth similar to organ growth with limited differences 
between sexes.  
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CHAPTER I 
REVIEW OF LITERATURE 
Introduction 
As humans and animals age, growth slows and eventually stops. Organs grow until they 
reach mature size, however, little is known about how growth cessation is regulated and 
coordinated. An understanding of the regulation of growth decline may be useful to alleviate and 
treat diseases such as cancer and undergrowth syndromes. Previously, a set of genes was 
identified that may be involved in the coordinated cessation of organ growth (Finkielstain et al., 
2009; Lui et al., 2008; Lui et al., 2010). Though these genes have been well characterized in 
organs, the expression patterns of these genes in growing muscle are unexplored. This discussion 
will focus on the previous research examining the downregulation of 7 of these genes (Ezh2, 
Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1) in organs with age and their overall functions along 
with specific functions identified in muscle. General muscle growth as well as a general 
comparison of muscle growth with that of organs will also be discussed.   
Downregulation of Growth Regulating Genes in Organs with Age 
A microarray analysis comparing 1 and 4 week old C57BL/6 male mouse lung, kidney, 
and heart tissue revealed over 1200 genes that were downregulated in all 3 organs (Finkielstain 
et al., 2009). Attention was focused on 5 of those genes (Igf2, Igf2bp3, Mest, Peg3, and Sox4) 
which had been previously identified as regulating growth (Curley et al., 2005; DeChiara et al., 
1990; Lefebvre et al., 1998; Liao et al., 2005; Ya et al., 1998). Igf2bp3 and Sox4, while involved 
in growth, have more often been implicated in embryonic growth than in postnatal growth. Real-
time PCR of 1, 4, and 8 week old male mouse mRNA from kidney, heart, lung, and liver 
revealed that expression of all 5 genes declined with age. Using in situ hybridization, it was 
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determined that the decline of Igf2, Mest, and Peg3 expression was due to an overall decrease of 
expression in each cell and not from a decrease in the number of cells expressing the genes.  
Though compelling, it is hard to tease apart if the observed downregulated expression 
was due to age or growth. Therefore, male Sprague Dawley rats were growth retarded by 
inducing hypothyroidism from 1 day to 5 weeks of age and allowed to recover from 5 to 9 weeks 
(Finkielstain et al., 2009). Generally, there was a decline of Igf2, Mest, and Peg3 expression 
from 3 to 9 weeks of age as expected in the kidney, liver, and heart of control rats. When 
compared at 7 and 9 weeks of age, the expression of Igf2, Peg3, and Mest was generally 
increased in the hypothyroid induced rats when compared to the controls. This pattern was not 
consistently observed between control and growth retarded mice for Sox4 or Igf2bp3. Due the 
fact that these 2 genes are more involved in embryonic development and are not affected by 
growth delay, they are not likely to be involved in postnatal growth regulation. The decline of 
expression with age may be residual remnants from increased embryonic expression. Overall, a 
mechanism of growth decline involving the downregulation of a set of growth regulating genes 
as animals age was proposed. As expression of these genes declines, growth begins to slow and 
eventually stops. This decline is dependent upon growth itself such that after growth restriction, 
expression of these genes increases with an expected increase in growth rate.  
Another investigation was conducted to find further evidence for a genetic program that 
regulates the cessation of growth (Lui et al., 2010). A microarray analysis was conducted 
comparing 1 and 5 week old male Sprague Dawley rat kidney and lung tissue. Using mouse data 
from a previous study (Finkielstain et al., 2009), 235 genes were downregulated with age in all 
organs and in both rodent species. To characterize the effects of certain genes more closely, 8 
genes (Ezh2, Gpc3, Mdk, Meis1, Mest, Mycn, Peg3, and Plagl1) were chosen based upon their 
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probable function as regulatory genes. Real-time PCR was performed on these genes in the lung, 
kidney, liver, and heart of male C57BL/6 mice and Sprague Dawley rats through 8 weeks of age. 
All genes in all organs of both rodents declined in expression with age, though, expression of 
Ezh2 and Mycn in mouse liver was downregulated more in embryonic stages than postnatally. 
Reduced expression thru siRNA transfection of most of these genes in hepatocytes from fetal 
mouse liver resulted in reduced proliferation. In contrast, Gpc3 knockdown resulted in greater 
proliferation of hepatocytes. These data indicate that these 8 genes are involved in growth 
regulation and as growth progresses, these genes decline in expression possibly causing the 
slowing and eventually ceasing of growth. However, the question of whether this downregulation 
is dependent upon age or growth still remains. To examine this, newborn male Sprague Dawley 
rats were growth delayed by feeding dams tryptophan deficient diets until 4 weeks of age when 
an adequate diet was resumed (Lui et al., 2010). Expression of the 8 previously identified genes 
was generally increased at 5 and 6 weeks in growth delayed rats when compared to controls. 
This strongly suggests that these genes are dependent on growth and not age.  
 This coordinated decline in expression might be orchestrated by epigenetic histone 
modifications in the promoter regions of these genes (Lui et al., 2010). The most consistently 
observed modification was decreased trimethyl-H3K4 (H3K4me3) from 1 to 4 weeks of age 
observed in the promoter regions of Mdk, Peg3, and Plagl1 in the kidney, liver, and lung of male 
mice. In a larger set of age related genes (11 downregulated and 5 upregulated), 7 downregulated 
genes had a decline of H3K4me3 in all 3 organs and 2 downregulated genes had a decline in 2 of 
the 3 organs. Only 2 upregulated genes showed a change in H3K4me3 with increased levels in at 
least 2 of the 3 organs. H3K4me3 is a signature of actively transcribing genes and permissive 
chromatins (Koch et al., 2007; Pokholok et al., 2005; Santos-Rosa et al., 2002; Yan and Boyd, 
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2006). Permissive chromatins have a more open structure while non-permissive chromatins are 
more compact (as reviewed by Lund and Zaina, 2009) . Genes within the permissive chromatin 
are potentially active while genes within the non-permissive chromatin are generally inactive (as 
reviewed by Berger, 2007). H3K3me3 recruits multiple effector molecules, some of which have 
activation functions, and, therefore, the decline of H3K4me3 with age might be indicative of 
decreased recruitment of activation transcription factors and, thus, less activation of these genes 
leading to the observed downregulation of expression.  
 These studies demonstrate that a large set of genes is downregulated in organs with age. 
Though this downregulation helps to slow postnatal growth, the expression of these genes is also 
dependent upon growth. The downregulation occurs through an overall decrease of expression in 
each cell and might be regulated by an H3K4me3 histone modification in the promoter region of 
these genes. This is a proposed mechanism of growth decline in organs, however, at this point, 
there has been limited data about these genes in growing muscle. To further understand the 
function of 7 of these genes (Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1), their general and 
specific functions in skeletal muscle will be discussed in more detail.  
Growth Regulating Gene Functions 
 Ezh2 encodes a Polycomb group protein methyltransferase, a subunit of the Polycomb-
repressive complex 2 (PRC2), which acts as a transcriptional repressor by trimethylating lysine 
27 of histone H3 (H3K27me3) (as reviewed by Sauvageau and Sauvageau, 2010). This 
methylation causes the repression of genes, such as the Hox, Pax, and Six genes, that are needed 
for the determination of cell lineage and differentiation of embryonic stem cells (Boyer et al., 
2006). Inactivation of this gene is lethal in mice as embryos ceased development between 
embryonic days 5-10 with incomplete gastrulation (O'Carroll et al., 2001). In muscle, Ezh2 is 
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needed for stem cells to commit to the muscle lineage and inactivation of the gene in satellite 
cells results in diminished postnatal muscle growth (Juan et al., 2011). Mutant mice with ablation 
of Ezh2 in satellite cells have reduced muscle mass and smaller fiber size than controls with less 
ability for muscle regeneration and satellite cell proliferation. There is unexpected expression of 
non-muscle lineage genes in the muscle tissue of these mutant mice suggesting that Ezh2 might 
normally repress non-myogenic cell lineages. In comparison, overexpression of Ezh2 represses 
certain muscle genes, such as myosin heavy chain and, in turn, reduces differentiation (Caretti et 
al., 2004). This might have implications in cancer as Ezh2 is also overexpressed in 
rhabdomyosarcoma, a cancer of skeletal muscle (Ciarapica et al., 2009). Overall, it is clear that 
Ezh2 is important not only for embryonic development and viability, but also for postnatal 
muscle growth. As muscle matures, it is expected that the expression of Ezh2 would decrease 
because there is less need for a large amount of satellite cell proliferation and differentiation into 
new muscle cells because rapid muscle growth has ceased.   
Gpc3 encodes a heparan sulfate proteoglycan that is membrane bound to the cell surface 
by a glycosylphosphatidylinositol (as reviewed by Filmus and Selleck, 2001). The exact 
mechanism of Gpc3 function is not known; however, it is directly involved with growth. Loss of 
function mutations in Gpc3 lead to the Simpson-Golabi-Behmel overgrowth syndrome (Pilia et 
al., 1996). This disease is characterized by skeletal and visceral abnormalities that include 
polydactyly, cleft palate, enlarged and cystic kidneys, enlarged head, supernumerary nipples, and 
hernias (Golabi and Rosen, 1984). Gpc3 deficient mice exhibit abnormalities similar to the 
Simpson-Golabi-Behmel overgrowth syndrome. These mice demonstrate pre and postnatal 
overgrowth symptoms including larger birth weights, placentas, and lungs than wild-types 
(Cano-Gauci et al., 1999; Chiao et al., 2002). Gpc3 deficient mice also have a delay in 
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endochondral ossification, decreased osteoclast differentiation, heart defects, and reduced 
viability (Cano-Gauci et al., 1999; Chiao et al., 2002; Ng et al., 2009; Viviano et al., 2005). No 
published research indicates muscle abnormalities in humans or mice deficient in Gpc3, though 
overexpression of the Gpc3 protein is noted in rhabdomyosarcoma indicating that it could have 
functions within muscle growth (Thway et al., 2011). Gpc3 is involved in hepatocyte growth and 
liver regeneration (Liu et al., 2009). In hepatocytes, a reduction in the expression of Gpc3 in 
culture results in increased proliferation. A partial hepatectomy in rats results in Gpc3 expression 
which peaks during the early and middle stages of regeneration. It is thought that Gpc3 is a 
negative regulator of growth such that increased expression causes a reduction in proliferation. 
With age, it is expected that Gpc3 expression will decline in organs and muscle because there is 
less need to negatively regulate proliferation when growth has ceased. Overall, Gpc3 is clearly 
involved with normal heart, liver, and bone growth as well as the development of 
rhabdomyosarcoma; therefore, it might also have implications in the normal development of 
muscle.  
Mdk encodes a heparin binding protein that has various effects on growth (Tomomura et 
al., 1990). In the nervous system, Mdk promotes neurite out-growth and migration (Kaneda et al., 
1996). Postnatally, Mdk knockout mice exhibit delayed brain development as well as a decrease 
in memory at 4 weeks of age (Nakamura et al., 1998). In humans, Mdk is thought to be involved 
with Alzheimer’s disease because ectopic Mdk protein has been found in the brain of 
Alzheimer’s patients located in senile plaques (Yasuhara et al., 1993). Additionally, when injury 
was induced to the sciatic nerve near the soleus, Mdk null mice had delayed nerve degeneration 
and regeneration properties which resolved by 5 weeks post-injury (Sakakima et al., 2009). In 
muscle, Mdk is expressed during the proliferation and differentiation of myoblasts, and levels are 
7 
 
increased in the early stages of muscle regeneration (Hu et al., 2002; Sakakima et al., 2006). 
Elevated levels are also prevalent following skin burns, gastric ulcers, bone fractures, heart 
infarctions, and brain infarctions indicating that Mdk may be involved in the repair of many 
different tissues (Fukui et al., 2008; Iwashita et al., 1999; Maekawa et al., 1999; Ohta et al., 
1999; Yoshida et al., 1995). Furthermore, Mdk is overexpressed in rhabdomyosarcoma cells 
demonstrating that Mdk has functions in both normal and abnormal muscle development (Jin et 
al., 2008). Overall, Mdk functions within various tissues all over the body and is involved in the 
muscle growth process. With age, Mdk expression is expected to decrease in organs and muscle 
because the proliferative characteristics of this gene are needed less as growth slows.  
Mycn (also known as N-myc) encodes a nuclear phosphoprotein with helix-loop-helix and 
leucine zipper regions that exhibit DNA binding (Landschulz et al., 1988; Murre et al., 1989; 
Prendergast and Ziff, 1989; Ramsay et al., 1986; Slamon et al., 1986). Loss of Mycn function 
leads to lethality at embryonic day 11, growth retardation, and several tissue defects in mouse 
models (Charron et al., 1992; Sawai et al., 1993; Stanton et al., 1992). The majority of these 
defects arise from the underdevelopment of the limb buds, lungs, heart, liver, gut, and urogenital 
tract. Mycn also plays a large role in the nervous system as it functions to promote the 
proliferation of neural progenitor cells and inhibit neural differentiation (Knoepfler et al., 2002). 
Though evident in many different tissues, Mycn has not been well characterized in skeletal 
muscle; however, this gene is overly expressed in rhabdomyosarcoma (Toffolatti et al., 2002; 
Williamson et al., 2005). Mycn may have the same functions it shows in neural progenitors, 
increased proliferation and decreased differentiation, in muscle progenitors to help this cancer 
advance. Overall, Mycn is essential for normal organgenesis, neurogenesis, and growth and 
might play a role in the normal development of skeletal muscle. With age, Mycn expression 
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would be expected to decline in organs and muscle as there is less need for the proliferative 
properties of this gene as growth slows. 
 Mest (also known as Peg1) and Peg3 (also known as Pw1) are similar in that both are 
paternally expressed imprinted genes that help regulate behavior (Lefebvre et al., 1998; Li et al., 
1999). The exact function of these two genes is still unknown. Mest encodes a protein that is 
similar in structure to an α/β hydrolase fold enzyme that has 8 β-sheets connected by α-helices 
(as reviewed by Leckman and Herman, 2002; Ollis et al., 1992). Peg3 encodes a C2H2 zinc 
finger protein which is involved with DNA binding (Kuroiwa et al., 1996; Relaix et al., 1996). 
When either gene is inactivated, it produces female mice with abnormal maternal behavior 
(Lefebvre et al., 1998; Li et al., 1999). Mutant females produce fewer offspring that live past 
weaning age, and the pups that do survive are small and growth stunted. Peg3 inactivation leads 
to pups that, after weaning, could catch up in growth to their wild-type counterparts while Mest 
inactivation leads to pups that are permanently growth retarded. For both genes, this reduction in 
growth results from abnormal maternal behaviors such as decreased nest building, pup retrieval, 
and nursing.  
Mest and Peg3 are also involved in regulating adipose deposition and adipocyte size. 
Obese mice have an increased expression of Mest in white adipocytes (Nikonova et al., 2008; 
Takahashi et al., 2005). Transgenic mice with an overexpression of Mest exhibit increased 
adipocyte size and increased expression of key adipogenic genes, such as leptin and GLUT4. 
When adipocyte size is reduced, Mest expression decreases. Mest knockout mice also have 
reduced epididymal and inguinal fat depot weights when compared to controls. Consequently, 
Peg3 has the opposite effect on fat accumulation. Peg3 inactivation leads to adult mice with 
increased white adipose tissue and leptin levels when compared to their wild-type counterparts 
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(Curley et al., 2005). These mice also have reduced food intake with a lower metabolic rate and 
body temperature. They fail to exhibit an increased body temperature when exposed to cold 
temperatures, which might explain why they have an increased accumulation of fat.  
Similar to Mest and Peg3, Plagl1 (also known as Zac1 and Lot1) is a paternally expressed 
imprinted gene that encodes a zinc finger protein that exhibits DNA binding and transactivation 
activity and might acts as a transcription factor (Kamiya et al., 2000; Spengler et al., 1997; 
Varrault et al., 1998). It also has some apoptotic and growth inhibition properties in tumors, 
though it is tumor specific because this is not observed in all cancers (Rezvani et al., 2012). In 
addition to cancer growth, Plagl1 is involved with normal growth. Plagl1 deficient mice exhibit 
smaller birth, hind limb, lung, and liver weights than wild-type controls with decreased 
ossification of the caudal vertebrae and ankle bones and reduced survivability (Varrault et al., 
2006). In the heart, Plagl1 is necessary for normal cardiac formation. Plagl1 null mice display 
heart malformations and increased apoptosis of cardiac cells which might play a role in the 
observed reduction in viability (Yuasa et al., 2010).    
Mest, Peg3, and Plagl1 are all important in muscle growth such that they are involved in 
muscle regeneration. Expression of these 3 genes was observed in the tibialis anterior during 
muscle regeneration after injury (Yan et al., 2003). In comparison, before injury, the muscle was 
irradiated with gamma radiation to inhibit satellite cell proliferation, and thus, block muscle 
regeneration. This resulted in no regeneration and no expression of Mest, Peg3, and Plagl1. This 
suggests that all 3 of these genes are associated with muscle regeneration and might have 
functions within satellite cell activation, proliferation, or differentiation. Additionally, Peg3 
inactivation in mice results in smaller hind limb muscle mass, a 60% reduction in fiber size as 
compared to wild-type mice at 6 days of age, and increased expression of Atrogin-1, a marker of 
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muscle atrophy (Curley et al., 2005; Nicolas et al., 2005). Furthermore, overexpression of these 3 
genes is evident in rhabdomyosarcoma while inhibition leads to decreased rhabdomyosarcoma 
cell proliferation (Rezvani et al., 2012). Overall, Mest, Peg3, and Plagl1 have important roles in 
the normal growth and development of several tissues as well as possible functions in muscle 
regeneration. With age, it is expected that the expression of these 3 genes in organs and muscle 
would decrease because as growth slows, there is less need for proliferation and less need for the 
proliferative functions that these genes supply.  
In summary, it is evident that these 7 genes are important for normal growth in many 
different tissues. Deficiencies lead to reduced viability as well as many growth defects and 
abnormalities. Several of these genes have also been associated with muscle growth. Inactivation 
mutations lead to reduced muscle mass and less ability for muscle regeneration. In addition, 
overexpression of all of these genes is observed in rhabdomyosarcoma, a mesodermal cancer that 
arises in skeletal muscle, further indicating a possible role in muscle development. With age, the 
expression of these genes is expected to decline as the need for their growth associated functions 
decreases. In order to better understand how these genes might play a role in muscle 
development, the regulation of normal skeletal muscle growth will be discussed in more detail.      
Skeletal Muscle Growth 
 Skeletal muscle growth can occur in two ways: hyperplasia, increase in cell number, and 
hypertrophy, increase in cell size. Muscle growth by hyperplasia occurs mainly during prenatal 
muscle growth, termed myogenesis, while postnatal growth is primarily the result of hypertrophy 
(Enesco and Puddy, 1964). The steps of myogenesis are controlled by many different muscle 
regulatory factors including MyoD, Myf5, myogenin, and MRF4 (as reviewed by Chong et al., 
2009). The first step during myogenesis is commitment of mesenchymal cells to the muscle 
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lineage, which is marked by the expression of MyoD and Myf5. Now termed myoblasts, these 
cells continue to proliferate until the upregulation of myogenin and MRF4 signal terminal 
differentiation. It should be noted that MRF4, while a terminal differentiator, also might have 
functions in commitment as well. The next step in prenatal muscle growth is fusion. This is when 
the myoblasts fuse together in a biphasic nature to form primary and secondary myotubes and 
results in a multi-nucleated muscle cell. The last step of myogenesis is myofibrillogenesis. This 
process involves the assembling of proteins into the structural units of muscle known as 
sarcomeres to produce mature, functional muscle.  
 Postnatally, muscle grows primarily by hypertrophy until it reaches its mature size. The 
muscle nuclei are unable to divide after fusion, so to acquire further nuclei and increase size, 
satellite cells are activated and fuse with the muscle fibers (Moss and Leblond, 1971; Stockdale 
and Holtzer, 1961). Satellite cells are myogenic stem cells that have a single, centrally located 
nucleus and are located between the sarcolemma and basal lamina of the muscle tissue (as 
reviewed by Shefer and Yablonka-Reuveni, 2007) . They are quiescent until activation by 
growth stimuli or muscle injury to produce myoblasts that fuse with existing muscle. When 
examining the function of the previous 7 genes in muscle growth, 5 of them have a large effect 
on muscle regeneration indicating that their function might be affecting satellite cell activation, 
proliferation, or differentiation.  
 Postnatal muscle growth differs from the postnatal growth of heart and liver. Similar to 
myocytes, cardiomyocytes lose their ability for hyperplastic growth shortly after birth (Li et al., 
1996). However, cardiomyocytes undergo approximately 2 weeks of binucleation without 
cytokinesis once hyperplastic growth has ceased. After binucleation, the cardiomyocytes are only 
capable of hypertrophic growth. In contrast, hepatocytes proliferate rapidly up to approximately 
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2 weeks of age when proliferation begins to decline (Chang et al., 2008). Even though declining, 
hepatocyte proliferation can extend up to at least 6 weeks of age. Additionally, hepatocytes are 
capable of hyperplastic and hypertrophic growth throughout the lifetime of humans and animals 
(as reviewed by Michalopoulos, 1990). Due to these growth differences, it is possible that the 
patterns of expression of these 7 growth dependent genes might differ between tissues.  
Objective 
 The objective of this study was to examine the expression patterns of 7 genes (Ezh2, 
Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1) in the heart, liver, and muscle of male and female 
mice over time. We expected the expression profiles to differ between males and females and 
differ between tissues because the expression of these genes is governed by growth. Males attain 
heavier body weights than females, so the expectation was that increased expression of these 
genes would be maintained for longer in males when compared to females. As mentioned earlier, 
postnatal growth differs between muscle, heart, and liver. These differences in growth indicate 
that there might be differences in the patterns of expression of these growth regulating genes 
between tissues. Over time, we expected that all of the genes in all of the tissues would decline 
as the mice age. These genes all have growth regulating functions and as the animal reaches 
mature size, it is necessary for these functions to be reduced. It is theorized that the decline of 
these genes coincides with reduced proliferation and the eventual cessation of growth.    
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CHAPTER II 
REDUCTIONS IN EXPRESSION OF GROWTH REGULATING GENES ARE 
OBSERVED IN SKELETAL MUSCLE AND ORGANS WITH AGE  
Abstract 
A set of growth regulating genes has been identified that decline in expression in organs 
with age. This downregulation is thought to coordinate organ growth cessation observed as 
humans and animals mature. The objective of this study was to observe the expression of 7 of 
these growth regulating genes (Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1) in male and 
female skeletal muscle, heart, and liver with age. It was hypothesized that the expression of these 
genes would differ not only between sexes, but also between tissues. Female and male C57BL/6J 
mice were sacrificed at 1, 7, 21, 35, and 49 days of age. Samples collected consisted of heart and 
liver from all mice, all muscles from both hind limbs of 1- and 7-day-old mice, and specific 
muscles (bicep femoris, gastrocnemius, tibialis anterior, and triceps brachii) from 21-, 35-, and 
49-day-old mice. Expression was determined by quantitative real-time PCR, normalized to 
Rn18s, standardized to a single 1-day-old male liver sample present on each plate, and compared 
to the average of 1-day-old male expression for each tissue. Data were analyzed using the Proc 
Mixed procedure in SAS as repeated measures with significant differences (P < 0.05) determined 
by a Bonferroni-adjusted pdiff. Orthogonal contrasts were used to differentiate between linear, 
quadratic, and cubic patterns of expression among tissues. In general, expression declined from 1 
or 7 days of age when compared to 49 days of age for all the genes in all the tissues except for 
expression of Ezh2 and Mycn, which was not altered by age in liver. Some differences in 
expression were observed between sexes with the majority of the differences occurring at 49 
days. Expression was usually increased in females compared with males at this time point. 
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Occasionally, males had greater expression than females; this was observed in liver at 1 day of 
age for Gpc3, Mest, and Plagl1 and muscle at 35 days of age for Mest. There were some 
similarities in the patterns of gene expression between muscle and heart or liver, but, there was 
not a single gene that had the same pattern of expression in all 3 tissues. Overall, these data 
suggest that the downregulation of these growth regulating genes with age might play a role in 
the coordinated cessation of muscle growth similar to organ growth with limited differences 
between sexes.  
Introduction  
As humans and animals age, growth slows and eventually stops. Organs grow until they 
reach mature size; however, little is known about how growth cessation is regulated and 
coordinated in the body. A set of growth regulating genes, which include Ezh2, Gpc3, Mdk, 
Mest, Mycn, Peg3, and Plagl1, has been identified that is dependent upon growth and whose 
expression declines with age in organs (Finkielstain et al., 2009; Lui et al., 2010). In general, 
when expression of these genes decreases, proliferation decreases leading to a reduction in 
growth. Mutations of these genes also result in reduced viability, growth abnormalities, and 
diseases such as rhabdomyosarcoma, a skeletal muscle cancer, and Simpson-Golabi-Behmel 
syndrome (Charron et al., 1992; Chiao et al., 2002; Ciarapica et al., 2009; Jin et al., 2008; 
Lefebvre et al., 1998; Li et al., 1999; Nakamura et al., 1998; O'Carroll et al., 2001; Pilia et al., 
1996; Rezvani et al., 2012; Sakakima et al., 2009; Sawai et al., 1993; Stanton et al., 1992; 
Toffolatti et al., 2002; Varrault et al., 2006; Williamson et al., 2005).  
Though well characterized in organs, these genes have not been well examined in 
growing muscle. It is expected that expression of these genes would differ between muscle, 
heart, and liver because of the differences in how these tissues grow. Postnatally, muscle grows 
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by hypertrophy, an increase in cell size, and not hyperplasia, an increase in cell number (Enesco 
and Puddy, 1964). After prenatal muscle fiber fusion and maturation, muscle nuclei are unable to 
divide. Satellite cells are activated and fuse with existing muscle fibers to increase muscle 
growth (Moss and Leblond, 1971; Stockdale and Holtzer, 1961). Without the activation of 
satellite cells, postnatal muscle growth and regeneration is severely inhibited. Similar to muscle, 
heart loses its ability for hyperplastic growth shortly after birth; however, cardiomyocytes 
undergo approximately 2 weeks of binucleation without cytokinesis once hyperplastic growth 
has ceased (Li et al., 1996). After binucleation, the cardiomyocytes are only capable of 
hypertrophic growth. In contrast, hepatocytes proliferate rapidly up to approximately 2 weeks of 
age when proliferation begins to decline (Chang et al., 2008). Even though declining, hepatocyte 
proliferation can extend up to at least 6 weeks of age. Additionally, hepatocytes are capable of 
hyperplastic and hypertrophic growth throughout the lifetime of humans and animals (as 
reviewed by Michalopoulos, 1990). Due to these growth differences, it is possible that the 
patterns of expression of these 7 growth dependent genes might differ between tissues. 
In muscle, it is known that the expression of Ezh2, Mdk, Mest, Peg3, and Plagl1 is 
increased during regeneration while regeneration is reduced when these genes are inactivated 
(Hu et al., 2002; Juan et al., 2011; Sakakima et al., 2006; Yan et al., 2003). In contrast, Mycn and 
Gpc3 have not been characterized in muscle. Mycn, however, increases proliferation of neural 
progenitor cells while Gpc3 is upregulated in the early and middle stages of liver regeneration 
(Knoepfler et al., 2002; Liu et al., 2009). Because 5 of 7 of these genes are known to be 
upregulated with muscle regeneration, it is possible that they are affecting muscle growth by 
increasing activation, proliferation, or differentiation of satellite cells. With age, the expression 
of all of these genes is expected to decline in both organs and muscle because the growth 
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regulating functions of these genes would be less necessary once growth has ceased.  The 
objectives of this study were to confirm the downregulation of these 7 genes in heart and liver 
with age, determine if these genes were downregulated in muscle with age, and compare the 
gene expression patterns between tissues along with observing any differences between males 
and females.  
Materials and Methods 
Animal procedures and sample collection 
All procedures were approved by the University of Illinois Institutional Animal Care and 
Use Committee. Mice from an internal C57BL/6J colony were allowed ad libitum access to 
pelleted rodent chow (Teklad F6 rodent diet, Harlan, Indianapolis, IN, USA) and tap water. 
Room temperature was maintained at 22°C with a 12 hour light/dark cycle. Male and female 
mice were bred in monogamous pairs and litters were weaned at 21 days of age. Weaned mice 
were group housed with littermates of the same sex. At 1, 7, 21 (+/- 1) days of age, and 35 and 
49 (+/- 2) days of age, mice were weighed and then euthanized by CO2 asphyxiation and 
decapitation. Mice were selected based upon the mean live body weight for each sex and age 
time point for a total of 54 male and 51 female mice. For the 1 day time point, 32 male and 23 
female mice were used. At 7 days, 10 male and 14 female mice were used.  At 21, 35, and 49 
days, 4-5 male and female mice were used. Samples collected consisted of heart and liver from 
all mice, all muscles from both hind limbs of 1- and 7-day-old mice, and specific muscles (bicep 
femoris, gastrocnemius, tibialis anterior, and triceps brachii) from 21-, 35-, and 49-day-old mice. 
Tissues were weighed and stored at -80°C for further analysis. Tissues weighing less than 50 mg 
were pooled within age and sex to create samples of at least 50 mg (1 and 7 days n = 5 pooled 
samples per sex per time point; 21, 35, and 49 days n = 4 pooled samples per sex per time point). 
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Because hearts were the smallest of the tissues at 1 and 7 days, mice were sacrificed until an 
adequate number of heart samples were collected to create 5 pooled 50 mg samples per sex; 
however, this resulted in an excess of muscle and liver samples. Therefore, tissues from mice 
that were closest to the mean live body weight were used for further analysis (n = 5 pooled 
samples per sex per time point). All data presented is reflective of only mice analyzed for gene 
expression. 
RNA Extraction and cDNA Synthesis 
Total RNA was extracted using TRI-Reagent (Sigma-Aldrich, St. Louis, MO, USA) and 
BCP phase separation reagent (Molecular Research Center, Inc., Cincinnati, OH, USA) 
according to the manufacturers’ protocols. RNA purity and concentration were measured using a 
NanoDrop 2000c spectrophotometer (Thermo Scientific, Wilmington, DE, USA). All samples 
had a 260/280 nm ratio between 1.9 and 2.1. For cDNA synthesis, RNA was diluted to 500 ng/µl 
using RNase-free water and 1 µg of RNA was reversed transcribed using the Quantitect Reverse 
Transcription Kit (Qiagen, Valencia, CA, USA).  
Quantitative real-time PCR 
Validation experiments were conducted according to the Applied Biosystems quantitative 
PCR manual (Applied Biosystems, 2004) to determine the appropriate reference gene (Rn18S) 
and cDNA dilution (1:32 for muscle and 1:64 for heart and liver) for this study. Eighteen µl of 
diluted cDNA, 2 µl of primer/probe, and 20 µl of Taqman Universal Master Mix (Roche, 
Branchburg, NJ, USA) were mixed together and plated in 10 µl triplicates into a 384-well plate. 
Expression of Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1 (Table 1) was determined by 
quantitative real-time PCR using an ABI Model 7900HT Fast Real-Time PCR System thermal 
cycler (Applied Biosystems, Foster City, CA, USA). The thermal cycler performed 40 cycles of 
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2 minutes at 50°C, 10 minutes and 15 seconds at 95°C, and 1 minute at 60°C. Expression was 
normalized to Rn18s (ΔCt), standardized to a single 1-day-old male liver sample present on each 
plate, and compared to the average of 1-day-old male expression for each tissue (ΔΔCt). Values 
were expressed as a fold change (2-ΔΔCt = fold change) compared to the 1-day-old male 
expression for each tissue.  
Statistical analysis 
Data were analyzed using the Proc Mixed procedure in SAS version 9.2 (SAS Institute 
Inc., Cary, NC, USA) as repeated measures with either an unstructured, autoregressive, or 
compound symmetry variance/covariance structure based on the lowest Akaike scores. The 
model included the fixed effects of age, sex, and their interaction. Samples were considered 
outliers if Proc Univariate identified them as an extreme outlier in 5 or more genes. The entire 
sample was removed from the expression and weight analyses for that tissue. Data are presented 
as least squares means ± s.e.m. with significant differences (P < 0.05) determined by a 
Bonferroni-adjusted pdiff. Orthogonal contrasts in Proc Mixed were used to differentiate 
between patterns of expression among tissues. Proc IML was used to determine the contrast 
coefficient matrix for unequal spacing of time.  
Results 
Body, muscle, heart, and liver weights  
 Body, muscle, heart, and liver weights were compared between males and females at 
each age time point to illustrate differences between sexes. For body and liver weights, there was 
an age and sex interaction (P < 0.01). Body and liver weights were similar between males and 
females at 1, 7, and 21 days of age, but males were heavier (P < 0.05) than females at 35 and 49 
days (Figures 1A and 1D). For heart weight, there was also an interaction of age and sex (P < 
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0.01) such that weights were similar between males and females through 35 days of age, but 
males were heavier (P < 0.05) at 49 days (Figure 1C). For muscle weight, there was an age and 
sex interaction (P < 0.01). Males and females had similar hind limb muscle weights at 1 and 7 
days of age and similar specific muscle weights at 21 and 35 days, but at 49 days of age, males 
had heavier (P < 0.05) gastrocnemius and trended toward heavier (P = 0.06) triceps brachii 
muscles than females (Figure 1B).  
Expression of growth regulating genes in heart and liver  
 The first objective of this study was to confirm the downregulation of expression of these 
growth regulating genes in heart and liver and to determine if sex affected expression. The 
expression of these genes in heart was affected by age (P < 0.01) such that expression at 1 day of 
age was greater (P < 0.05) than expression at 49 days of age (Figure 2). Expression of Gpc3 and 
Mest were affected by an age and sex interaction (P < 0.05); however, means between sexes at 
each age time point for Mest were not different (P > 0.60) while females had greater (P < 0.05) 
Gpc3 expression than males only at 49 days of age. Overall, there was not an effect (P > 0.10) of 
sex on expression of these genes in heart.  
In liver, the expression of Gpc3, Mdk, Mest, Peg3, and Plagl1 was affected by age (P < 
0.01) such that expression at 1 day was greater (P < 0.05) than expression at 49 days (Figure 3). 
However, the expression of Ezh2 and Mycn were not altered (P > 0.25) by age in this study. 
Expression of Gpc3, Mest, and Plagl1 were affected by an age and sex interaction (P < 0.01) 
such that expression in males was greater (P < 0.05) than expression in females at 1 day, but 
sexes were similar at 7, 21, 35, and 49 days. Interestingly, Peg3 expression was also affected by 
an age and sex interaction (P < 0.01); however, this interaction differs from the others in that 
sexes are similar in expression at 1, 7, 21, and 35 days of age and females are greater (P < 0.05) 
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than males at 49 days. Though unaffected by age, expression of Mycn was affected (P < 0.05) by 
sex such that males had greater (P < 0.05) expression than females. There was an age and sex 
interaction (P < 0.05) for Ezh2 expression, but means between sexes at each age time point were 
not different (P > 0.20).     
Expression of growth regulating genes in muscle  
The second objective was to determine if these genes were downregulated with age in 
muscle and if expression was different between males and females. All muscles from both hind 
limbs were collected at 1 and 7 days of age because of the small size of individual specific 
muscles. From 21 days of age and on, specific muscles were collected and expression was 
measured in each muscle. Therefore, it was first appropriate to determine the effect of specific 
muscle on gene expression. All expression was compared to 1-day-old male hind limb 
expression allowing for direct comparison of fold change. The main effect of specific muscle on 
gene expression revealed that there were inconsistent patterns of differences between specific 
muscles and the magnitude of these differences was small (Table 2). However, expression of 
Ezh2 and Mycn were affected by a three-way age, sex, and specific muscle interaction (P < 0.10), 
but no clear pattern of differences between muscles was detected (Figure A.1 and Figure A.2). 
For each sex, means between muscles were not different (P > 0.30) within each age time point. 
Peg3 and Gpc3 also had a two-way interaction of age and specific muscle (P < 0.10). Means 
within age for Gpc3 were not different (P > 0.60, Figure A.3). For Peg3, the biceps femoris and 
tibialis anterior had greater (P < 0.05) expression than the gastrocnemius and triceps brachii at 35 
days and the tibialis anterior had greater (P < 0.05) expression than the other muscles at 49 days, 
but expression at these age time points only ranged from 0.15 to 0.35 (Figure A.4). Overall, 
analysis of the effect of specific muscle on gene expression revealed few additional interactions 
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of specific muscle with age or sex (P > 0.20); therefore, data presented in Figure 4 are pooled 
between all muscles within sex. 
Expression of Mdk was similar between males and females over time (Figure 4, age and 
sex interaction P = 0.83). For all other genes, there was an interaction of age and sex (P < 0.01). 
Differences between males and females occurred exclusively at 35 and 49 days of age. Females 
had greater (P < 0.05) expression of Ezh2, Gpc3, Mycn, Peg3, and Plagl1 than males at 49 days. 
Males had greater (P < 0.05) expression of Mest than females at 35 days. All genes were affected 
(P < 0.01) by age with an overall decline (P < 0.05) from either 1 or 7 day expression levels as 
age increased.       
Comparison of expression patterns between tissues 
 The third objective was to compare the patterns of expression of each gene between 
tissues. As each tissue was normalized to the 1-day-old male expression of that tissue, direct 
comparisons of fold changes are not appropriate to compare absolute amount of expression 
between tissues. Therefore, expression between males and females was pooled and linear, 
quadratic, and cubic contrasts were performed to determine the best fit to describe the expression 
patterns of each gene in each tissue (Figure 5). In muscle, the downregulation of these genes was 
primarily a cubic pattern of expression with the exception being Peg3 which had a quadratic 
pattern. In heart, the patterns of expression decline were split between quadratic and cubic. Ezh2, 
Mdk, and Mycn had quadratic patterns while Gpc3, Mest, Peg3, and Plagl1 had cubic patterns. 
Mest and Plagl1 had linear patterns of decline in liver while Gpc3 and Peg3 had quadratic 
patterns and Mdk had a cubic pattern. Ezh2 and Mycn expression did fit into the pattern of 
expression categories because they did change with age in liver. There were no genes were the 
pattern of expression decline was the same for all tissues. Between muscle and heart, there were 
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3 genes (Gpc3, Mest, and Plagl1) that had similar patterns of expression and between muscle and 
liver, there were 2 genes (Mdk and Peg3) that had similar patterns of expression. There were no 
genes between heart and liver with similar patterns of downregulation.  
Discussion 
Previous research had identified a large set of growth regulating genes whose expression 
was dependent upon growth and was downregulated in organs with age (Finkielstain et al., 2009; 
Lui et al., 2010). In general, this downregulation decreased proliferation and, in turn, may be 
involved in growth cessation. Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1 are part of this 
group of genes. These genes are downregulated with age in the heart, liver, lung, and kidney of 
mice and rats (Finkielstain et al., 2009; Lui et al., 2010). We investigated the expression of these 
genes in the muscle, heart, and liver of male and female mice over time to examine differences 
between sexes and tissues.  
Our first objective was to confirm the downregulation of these genes in heart and liver 
and determine if there were any differences in expression between sexes. Though, there has been 
little comparison of expression of these genes between males and females, we expected 
differences because males achieve larger body, heart, and liver weights than females. In our 
results, males achieved larger body and liver weights at 35 and 49 days when compared to 
females and males attained larger heart weights than females at 49 days. Under this assumption, 
males were predicted to have increased expression levels maintained longer than females. To that 
end, Gpc3, Mest, and Plagl1 expression was greater in males than females in liver at 1 day of 
age. However, surprisingly, there were few other differences between sexes in heart and liver. 
Females had greater Gpc3 and Peg3 expression than males at 49 days of age; however, 
expression at this time point is low and the expression differences are small, therefore, they 
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might not have a large effect on growth. In general, the expression of most of these genes 
declined from 1 day expression levels when compared to 49 day levels in heart and liver. This is 
not surprising considering that these genes have growth regulating functions, mostly 
proliferative, that are less needed as growth ceases. However, contrary to previous data, Ezh2 
and Mycn expression did not decline with age in liver. This may be attributed to the lack of 
prenatal time points. In addition to looking at postnatal ages, previous research had examined 
embryonic time points as well. In particular, Ezh2 and Mycn are highly expressed in the prenatal 
liver and show smaller declines of expression after birth (Lui et al., 2010). With only postnatal 
time points, any downregulation which may have occurred since embryonic development was 
undetected. Overall, there are few expression differences between sexes and in general, we 
confirmed the downregulation of most of these genes in heart and liver with age.  
Our second objective was to examine the expression of these genes in muscle and 
determine if there were any differences between sexes in this tissue. We expected males to have 
increased expression of these genes maintained for longer when compared to females because 
males attain larger body and muscle weights (Gall and Kyle, 1968; Rowe and Goldspink, 1969). 
In our results, however, not all muscle weights differed between sexes. Males had heavier 
gastrocnemius weights and trended towards heavier triceps brachii weights when compared to 
females at 49 days of age but, there were no other differences in muscle weight. There were also 
no large consistent differences in expression of these genes between specific muscles. 
Nevertheless, there were expression differences between males and females. Unexpectedly, the 
majority of those differences resulted from females having increased, not reduced, expression 
when compared to males at 49 days of age. In general, expression at these time points was low 
and the expression differences were small indicating that they might not have a large effect on 
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growth. The only exception is Ezh2 and Mycn were the differences between sexes were larger, 
but still biased with expression increased in females compared to males and not the reverse as 
predicted.  
As age increased, all of the genes were downregulated from 1 or 7 day expression levels 
in muscle. Ezh2, Mdk, Mest, Peg3, and Plagl1 are known to be involved in muscle regeneration 
and all of the genes are overly expressed in rhabdomyosarcoma, a skeletal muscle cancer 
(Ciarapica et al., 2009; Jin et al., 2008; Juan et al., 2011; Rezvani et al., 2012; Sakakima et al., 
2006; Thway et al., 2011; Toffolatti et al., 2002; Williamson et al., 2005; Yan et al., 2003). It is 
possible that these genes are aiding in postnatal muscle growth by activation, proliferation, or 
differentiation of satellite cells. It is already known that Ezh2 is involved in satellite cell 
activation (Juan et al., 2011). Mdk, Mest, Peg3, and Plagl1 might have similar functions because 
they are also involved in muscle regeneration (Sakakima et al., 2006; Yan et al., 2003). Mycn has 
not been well characterized in muscle, but it promotes the proliferation of neural progenitor cells 
and inhibits neural differentiation  and, therefore, might exhibit similar functions in muscle with 
regard to satellite cells (Knoepfler et al., 2002). It is not surprising that these genes would 
decrease over time as there is less activation, proliferation, and differentiation of satellite cells 
and, thus, less need for the growth regulatory functions of these genes as growth slows. In 
contrast, Gpc3 is thought be a negative regulator of growth such that increased expression results 
in reduced proliferation (Liu et al., 2009). Gpc3 functions in muscle have not been identified; 
however, Gpc3 is involved in liver regeneration such that expression peaks during the early and 
middle stages of the process (Liu et al., 2009). This leads to the conclusion that Gpc3 expression 
might increase early in postnatal development to negatively regulate growth and proliferation, so 
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overgrowth of organs and muscle does not occur, and decrease as growth slows because 
proliferation has decreased leading to less need for its regulatory functions.  
Our third objective was to compare the patterns of expression of each gene between the 3 
tissues. We expected the patterns of expression to differ between tissues because the postnatal 
growth of these tissues differs. Though there were no genes were the pattern of expression was 
the same for all 3 of the tissues, our hypothesis was not completely validated. For 5 of the genes, 
the patterns of expression were the same when compared between muscle and one of the organs. 
It is thought that the regulation of these genes in organs might occur by an epigenetic histone 
modification, trimethylated lysine 4 of histone H3 (H3K4me3), in the promoter region of these 
genes as the levels of H3K4me3 decreased with increased age (Lui et al., 2010). H3K4me3 is a 
signature of actively transcribing genes and permissive chromatins (Koch et al., 2007; Pokholok 
et al., 2005; Santos-Rosa et al., 2002; Yan and Boyd, 2006). Permissive chromatins have a more 
open structure while non-permissive chromatins are more compact (as reviewed by Lund and 
Zaina, 2009). Genes within the permissive chromatin are potentially active while genes within 
the non-permissive chromatin are generally inactive (as reviewed by Berger, 2007). H3K4me3 
recruits multiple effector molecules, some of which have activation functions, and, therefore, the 
decline of H3K4me3 with age might be indicative of decreased recruitment of activation 
transcription factors and, thus, less activation of these genes leading to the observed 
downregulation of expression. There are some similarities between the expression patterns in 
organs and muscle indicating that the same potential regulation by H3K4me3 might be present in 
all 3 tissues.  
In summary, this study examined the expression decline of 7 growth regulating genes 
over time in the muscle, heart, and liver of male and female mice. Overall, most of the genes 
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were downregulated with age in all 3 tissues. There were some differences between males and 
females, but the significance of these differences has yet to be determined. There are also some 
similarities in the patterns of expression of these genes between tissues indicating that these 
genes might be regulated similarly in multiple tissues, possibly by an H3K4me3 histone 
modification. Further research needs to be conducted to examine the regulation of these genes in 
muscle and satellite cells and confirm that an H3K4me3 histone modification is involved with 
the regulation of these genes. Knockdown assays in cultured satellite cells would be helpful to 
understand the effect these genes have on the proliferation and differentiation of postnatal 
muscle progenitor cells. In conclusion, these genes are known to be important in the cessation of 
organ growth. Now, this study has found that these genes might also help regulate the cessation 
of postnatal muscle growth potentially by regulating the activation, proliferation, and 
differentiation of satellite cells.  
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Tables and Figures 
Table 1. ABI primer probes. 
Gene 
Symbol Gene Name 
Reference 
Sequence ABI Assay ID 
Ezh2 Enhancer of zeste homolog 2  NM_007971.2 
NM_001146689.1  
Mm00468464_m1 
Gpc3 Glypican 3 NM_016697.3 Mm00516722_m1 
Mdk Midkine NM_010784.4 Mm00440279_m1 
Mest Mesoderm specific transcript NM_008590.1 Mm00484993_m1 
Mycn V-myc myelocytomatosis viral 
related oncogene, neuroblastoma 
derived  
NM_008709.3 Mm00476449_m1 
Peg3 Paternally expressed 3 NM_008817.2 Mm01337379_m1 
Plagl1 Pleiomorphic adenoma gene-like 1 NM_009538.2 Mm00494250_m1 
Rn18s 18S ribosomal RNA NR_003278.1 Mm03928990_g1 
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Table 2. Fold change of specific muscles in each gene.
1 
Gene Biceps Femoris Gastrocnemius Tibialis Anterior Triceps Brachii SEM 
Ezh2 1.456 1.609 1.506 1.489 0.075 
Gpc3 0.117b 0.139ab 0.112b 0.149a 0.008 
Mdk 0.160 0.257 0.243 0.157 0.033 
Mest 0.029b 0.049a 0.049a 0.034b 0.003 
Mycn 0.462b 0.763a 0.755a 0.672a 0.043 
Peg3 0.251b 0.203bc 0.311a 0.194c 0.013 
Plagl1 0.044ab 0.049a 0.036b 0.041ab 0.003 
  
1Values are least squares means. Expression was pooled between sexes and time points for 
analysis. Fold change is compared to the average male 1-day-old muscle expression.  
abMeans within a row without a common superscript are different (P < 0.05). 
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Figure 1. Increasing body weight (A), muscle weight (B), heart weight (C), and liver weight 
(D) with age. (B) From 1-7 days, muscle weight includes all muscles from one hind limb, and 
from 21-49 days, muscle weight is depicted as specific muscles. (A-D) Plotted values are least 
squares means displayed with standard error bars. Asterisks indicate a difference (P < 0.05) 
between sexes within age group.  
 
 
 
 
 
 
 
 
 
 
  
7 14 21 28 35 42 49
0
5
10
15
20
25
*
*
Female
Male
Age P < 0.01
Sex P < 0.01
Interaction P < 0.01
1
Age (Days)
B
o
d
y
 W
ei
g
h
t 
(g
)
7 14 21 28 35 42 49
0
25
50
75
100
125
150
Female BF
Female G
Female TA
Female TB
Male BF
Male G
Male TA
Male TB
Female Hind
Limb Muscle
Male Hind
Limb Muscle
Age P < 0.01
Sex P < 0.01
Interaction P < 0.01
1
Age (Days)
M
u
sc
le
 W
ei
g
h
t 
(m
g
)
7 14 21 28 35 42 49
0
20
40
60
80
100
120
140
Female
Male
*Age P < 0.01
Sex P = 0.06
Interaction P < 0.01
1
Age (Days)
H
ea
rt
 W
ei
g
h
t 
(m
g
)
7 14 21 28 35 42 49
0
200
400
600
800
1000
1200
1400
Female
Male
*
*Age P < 0.01
Sex P < 0.01
Interaction P < 0.01
1
Age (Days)
L
iv
er
 W
ei
g
h
t 
(m
g
)
A B
C D
42 
 
Figure 2. Expression of growth regulating genes in heart with age. Plotted values are least 
squares means displayed with standard error bars. Asterisks indicate a difference (P < 0.05) 
between sexes within age group. Fold change is compared to the average male 1-day-old heart 
expression. 
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Figure 3. Expression of growth regulating genes in liver with age. Plotted values are least 
squares means displayed with standard error bars. Asterisks indicate a difference (P < 0.05) 
between sexes within age group. Fold change is compared to the average male 1-day-old liver 
expression. 
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Figure 4. Expression of growth regulating genes in muscle with age. Plotted values are least 
squares means displayed with standard error bars. Expression of specific muscles for 21-49 days 
was pooled for analysis purposes. Asterisks indicate a difference (P < 0.05) between sexes within 
age group. Fold change is compared to the average male 1-day-old muscle expression. 
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Figure 5. Comparison of expression between muscle, heart, and liver with age. Plotted 
values are least squares means. The pattern of expression is indicated by a linear, quadratic, or 
cubic decline. Male and female expression and expression of specific muscles for 21-49 days 
were pooled for analysis purposes. Fold change is compared to the average male 1-day-old 
expression for each tissue.  
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APPENDIX 
Figure A.1. Age and specific muscle interaction for Ezh2 expression. Plotted values are least 
squares means displayed with standard error bars. Fold change is compared to the average male 
1-day-old muscle expression. 
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Figure A.2. Age and specific muscle interaction for Mycn expression. Plotted values are least 
squares means displayed with standard error bars. Fold change is compared to the average male 
1-day-old muscle expression. 
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Figure A.3. Age and specific muscle interaction for Gpc3 expression. Plotted values are least 
squares means displayed with standard error bars. Expression between sexes was pooled for 
analysis purposes. Fold change is compared to the average male 1-day-old muscle expression. 
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Figure A.4. Age and specific muscle interaction for Peg3 expression. Plotted values are least 
squares means displayed with standard error bars. Expression between sexes was pooled for 
analysis purposes. Means at 35 and 49 days without a common letter differ (P < 0.05). Fold 
change is compared to the average male 1-day-old muscle expression. 
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